Header Logo

Connection

Bette Caan to Survival Rate

Back to Details
This is a "connection" page, showing publications Bette Caan has written about Survival Rate.
Bette Caan
Connection Strength
0.657
Survival Rate
  1. Body mass index, PAM50 subtype, recurrence, and survival among patients with nonmetastatic breast cancer. Cancer. 2017 Jul 01; 123(13):2535-2542.
    View in: PubMed
    Score: 0.137
  2. Prognostic impact of comorbidity among long-term breast cancer survivors: results from the LACE study. Cancer Epidemiol Biomarkers Prev. 2012 Jul; 21(7):1115-25.
    View in: PubMed
    Score: 0.098
  3. Pre-diagnosis body mass index, post-diagnosis weight change, and prognosis among women with early stage breast cancer. Cancer Causes Control. 2008 Dec; 19(10):1319-28.
    View in: PubMed
    Score: 0.076
  4. Postdiagnosis Loss of Skeletal Muscle, but Not Adipose Tissue, Is Associated with Shorter Survival of Patients with Advanced Pancreatic Cancer. Cancer Epidemiol Biomarkers Prev. 2019 12; 28(12):2062-2069.
    View in: PubMed
    Score: 0.041
  5. Relationship of prediagnostic body mass index with survival after colorectal cancer: Stage-specific associations. Int J Cancer. 2016 09 01; 139(5):1065-72.
    View in: PubMed
    Score: 0.032
  6. Validation of self-reported comorbidity status of breast cancer patients with medical records: the California Breast Cancer Survivorship Consortium (CBCSC). Cancer Causes Control. 2016 Mar; 27(3):391-401.
    View in: PubMed
    Score: 0.032
  7. History of Recreational Physical Activity and Survival After Breast Cancer: The California Breast Cancer Survivorship Consortium. Am J Epidemiol. 2015 Jun 15; 181(12):944-55.
    View in: PubMed
    Score: 0.030
  8. An evaluation and replication of miRNAs with disease stage and colorectal cancer-specific mortality. Int J Cancer. 2015 Jul 15; 137(2):428-38.
    View in: PubMed
    Score: 0.029
  9. Diabetes and other comorbidities in breast cancer survival by race/ethnicity: the California Breast Cancer Survivorship Consortium (CBCSC). Cancer Epidemiol Biomarkers Prev. 2015 Feb; 24(2):361-8.
    View in: PubMed
    Score: 0.029
  10. The California Breast Cancer Survivorship Consortium (CBCSC): prognostic factors associated with racial/ethnic differences in breast cancer survival. Cancer Causes Control. 2013 Oct; 24(10):1821-36.
    View in: PubMed
    Score: 0.027
  11. Genetic variation in C-reactive protein in relation to colon and rectal cancer risk and survival. Int J Cancer. 2011 Jun 01; 128(11):2726-34.
    View in: PubMed
    Score: 0.022
  12. Migraine history and breast cancer risk among postmenopausal women. J Clin Oncol. 2010 Feb 20; 28(6):1005-10.
    View in: PubMed
    Score: 0.021
  13. Medical comorbidities predict mortality in women with a history of early stage breast cancer. Breast Cancer Res Treat. 2010 Aug; 122(3):859-65.
    View in: PubMed
    Score: 0.021
  14. Repeated measures of serum glucose and insulin in relation to postmenopausal breast cancer. Int J Cancer. 2009 Dec 01; 125(11):2704-10.
    View in: PubMed
    Score: 0.021
  15. The Pathways Study: a prospective study of breast cancer survivorship within Kaiser Permanente Northern California. Cancer Causes Control. 2008 Dec; 19(10):1065-76.
    View in: PubMed
    Score: 0.019
  16. Plasma carotenoids and recurrence-free survival in women with a history of breast cancer. J Clin Oncol. 2005 Sep 20; 23(27):6631-8.
    View in: PubMed
    Score: 0.015
  17. Hormone replacement therapy, reproductive history, and colon cancer: a multicenter, case-control study in the United States. Cancer Causes Control. 1997 Mar; 8(2):146-58.
    View in: PubMed
    Score: 0.009

© 2024 Kaiser Permanente